RAMON
CISTERNA CANCER
Investigador/a en el periodo 1981-2017
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Clínico Universitario Lozano Blesa (13)
2018
-
Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among gram-negative organisms recovered during the SMART study in Spain (2011-2015)
Revista Espanola de Quimioterapia, Vol. 31, Núm. 2, pp. 136-145
2012
-
The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?
Clinical Microbiology and Infection, Vol. 18, Núm. 7
2011
-
Antimicrobial susceptibility of gram-negative organisms from intra abdominal infections and evolution of isolates with extended spectrum β-lactamases in the smart study in spain (2002-2010)
Revista Espanola de Quimioterapia, Vol. 24, Núm. 4, pp. 223-232
2008
-
Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277
2007
-
Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)
Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229
2006
-
Patrones de sensibilidad a antimicrobianos de Enterobacteriaceae causantes de infecciones intraabdominales en España: Resultados del estudio SMART 2003
Revista Espanola de Quimioterapia, Vol. 19, Núm. 1, pp. 51-59
2005
-
Sensibilidad in vitro a los antibióticos y serotipos más frecuentes de Streptococcus pneumoniae. Estudio multicéntrico
Revista Espanola de Quimioterapia, Vol. 18, Núm. 1, pp. 45-51
-
Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: Correlation with results of NCCLS M27-A2 multicenter study
Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 4, pp. 1604-1607
2003
-
Pseudomonas aeruginosa: Estudio multicéntrico en 136 hospitales Españoles
Revista Espanola de Quimioterapia, Vol. 16, Núm. 1, pp. 41-52
2002
-
Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]
Journal of Antimicrobial Chemotherapy
2000
-
Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: The impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics
Journal of Antimicrobial Chemotherapy, Vol. 46, Núm. 4, pp. 557-564
1999
-
Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996-1997) multicenter surveillance study
Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 2, pp. 357-359
-
Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: Results of a 1-year (1996-1997) multicenter surveillance study
Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 1, pp. 178-180